PSMA-617.TFA
: (((S)-1-carboxy-5-((S)-3-(naphthalen-2-yl)-2- ((1r,4S)-4-((2-(4,7,10-tris(carboxymethyl)- 1,4,7,10-tetraazacyclododecan-1- yl)acetamido)methyl)cyclohexane-1- carboxamido)propanamido)pentyl)carbamoyl)- L-glutamic acid tetra(trifluoroacetic acid)
: PSMA-617 - a novel theranostic PSMA inhibitor for both diagnosis and endoradiotherapy of prostate cancer.
: PS 0495 (OTTO) PSMA-617.TFA Cas 1702967-37-0 - used in chemical research.
Properties
: Colourless to white to off-white
Safety Information
Safety Information for this product is unavailable at this time.
| Packings | Price (INR) |
|
1 mg
|
POR
|
|
5 mg
|
POR
|
|
1 gm
|
POR
|